Health & Fitness
The Multiple Myeloma Research Foundation (MMRF) Annual Fall Gala to Benefit Cancer Research
John Legend to perform, Bonnie Hunt to serve as Mistress of Ceremonies, Professor - author Elie Wiesel and Karen E. Andrews to be honored.

The Multiple Myeloma Research Foundation (MMRF) Annual Fall Gala will be held on Saturday, October 24, in Old Greenwich, at the Hyatt Regency Greenwich Hotel.
Reception and silent auction will begin at 6 p.m. and dinner, a live auction and entertainment will begin at 7 p.m. Oscar- and Grammy-Award Winning Singer and Songwriter, John Legend will perform.
The evening’s Courage and Commitment honoree is Professor and Author Elie Wiesel, Nobel Laureate, and the Wiesel Family. Karen E. Andrews, MMRF Co-Founder and current member of the MMRF Board of Directors, will be honored with the Spirit of Hope Award.
Find out what's happening in Greenwichfor free with the latest updates from Patch.
The evening’s Mistress of Ceremonies is Bonnie Hunt, Actress, Director, Producer and Writer and MMRF Honorary Board of Directors.
For more information about the MMRF Annual Fall Gala, please visit: www.themmrf.org/FallGalaTickets. To reserve a table or inquire about sponsorship opportunities, please email mmrf@benefitoffice.org or call 888-584-5463.
Find out what's happening in Greenwichfor free with the latest updates from Patch.
About Multiple Myeloma
Multiple myeloma is a cancer of the plasma cell. It is the second most common blood cancer. An estimated 26,850 adults (14,090 men and 12,760 women) in the United States will be diagnosed with multiple myeloma in 2015 and an estimated 11,240 people are predicted to die from the disease.
About the Multiple Myeloma Research Foundation (MMRF)
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy’s diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world’s number-one private funder of multiple myeloma research, the MMRF has raised $300 million since its inception and directs nearly 90% of total budget to research and related programming.